CLINICAL_TRIALS
trial_result
· 2022-07-14
Clinical Trial Update: Apremilast for RAS [Phase 4]
Summary
Phase 4 trial of apremilast for recurrent aphthous stomatitis completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Recurrent Aphthous Stomatitis | Phase 4 | Status: COMPLETED | Results posted: 2022-07-14